We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Quantinuum Q3 Preview: Should You Buy the Dip Ahead of Earnings?
Read MoreHide Full Article
Key Takeaways
Quantinuum shares have plunged 38.7% since July despite major partnerships and technological progress.
Q3 revenues are estimated to be $8.15M, while adjusted loss is expected to widen to 38 cents per share.
Oracle's partnership, $100 million government award and expanding Nexus ecosystem could boost bookings.
Quantinuum Inc. (QNT - Free Report) is scheduled to report its third-quarter 2026 results on Nov. 5, after market close. The quantum computing company is heading into its second earnings announcement as a public company amid a steep decline in its share price and weakening investor sentiment toward pure-play quantum computing stocks.
Since the beginning of July, QNT shares have plunged 38.7%, significantly underperforming the Internet Software Market, which advanced 16.4% and the S&P 500 index, which gained 1.7%, according to the supplied Zacks price-performance data.
July-September QNT Stock Performance
Image Source: Zacks Investment Research
What Do Q3 Earnings Estimates for QNT Say?
The Zacks Consensus Estimate for Quantinuum's third-quarter 2026 revenues is pegged at $8.15 million, based on three analyst estimates. The Zacks Consensus Estimate for third-quarter bottom line is pegged at a loss of 38 cents per share, based on four analyst estimates.
The company reported second-quarter revenues of $8 million, reflecting 279% year-over-year growth. Adjusted net loss per share was 28 cents. The third-quarter consensus estimates therefore indicate modest revenue growth and a widening adjusted loss per share sequentially.
The stock's weakness during July to September was particularly notable considering Quantinuum's strategic developments since its June 2026 initial public offering (IPO). The company announced a major partnership with Oracle (ORCL - Free Report) , strengthened its manufacturing ecosystem through a collaboration with Quanta Computer and finalized a $100 million award agreement with the U.S. Department of Commerce's CHIPS Research and Development Office. It also reported encouraging technological progress on its Helios quantum computer and continued advancing its next-generation Sol system.
However, Quantinuum is not alone in facing investor skepticism. Other pure-play quantum computing companies, including IonQ (IONQ - Free Report) and D-Wave Quantum (QBTS - Free Report) , have also struggled to sustain their share-price momentum despite significant commercial and technological developments. IonQ's revenue growth, expanded strategic partnerships and progress on its next-generation quantum systems are yet to fully offset concerns about its substantial operating losses and commercialization timelines. Similarly, D-Wave's strong bookings growth and government-backed initiatives have not insulated its shares from the broader sector correction.
The broader quantum computing sector has struggled as investors have become increasingly cautious about speculative growth stocks, commercial adoption timelines and the substantial investment required to develop fault-tolerant quantum computers. Quantinuum's relatively small revenue base and widening operating losses have added to concerns.
For the third quarter, the extent to which the company's expanding commercial ecosystem translates into stronger bookings, remaining performance obligations (RPO) and improved revenue visibility will be crucial.
Oracle Deal and Government Funding Strengthen Commercial Prospects
Quantinuum strengthened its commercial and manufacturing ecosystem through several strategic developments during July-September, which could support bookings and future revenue growth. On Aug. 11, it announced a partnership with Oracle to deploy its Helios quantum computer through Oracle Cloud Infrastructure, enabling enterprise customers to combine quantum computing with conventional high-performance computing and AI workloads. However, management indicated that much of the deal's revenue contribution would materialize upon system delivery.
On Aug. 13, Quantinuum partnered with Quanta Computer to strengthen manufacturing and systems engineering capabilities. It also finalized a $100 million award agreement with the U.S. Department of Commerce's CHIPS Research and Development Office on Sept. 8 to support domestic quantum semiconductor manufacturing and supply-chain development, alongside GlobalFoundries and Monarch Quantum.
These developments provide important indicators for the third quarter. Technology progress also remains important. Quantinuum achieved near five-nines logical fidelity on Helios and continued validating its Sol system, targeted for 2027. More than 180 organizations were developing applications on its Nexus platform in the second quarter, up from approximately 150 earlier in the year. Whether this expanding ecosystem translates into higher bookings, RPO and improved revenue visibility will be crucial to the third-quarter results.
What the Zacks Model Unveils for QNT Stock
Our proven model predicts an earnings beat for Quantinuum this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
Earnings ESP: Quantinuum has an Earnings ESP of +20.53%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Should Investors Buy QNT Stock Ahead of Q3 Earnings?
Quantinuum has several fundamental strengths, including its full-stack quantum computing platform, technological leadership in trapped-ion systems, substantial cash reserves, an Oracle partnership and government-backed manufacturing initiatives. Its expanding Nexus ecosystem and progress toward Sol also support its long-term growth prospects.
However, the company's near-term financial profile remains challenging. The Zacks Consensus Estimate indicates modest sequential revenue growth and a wider adjusted loss for the third quarter. The absence of positive earnings estimate revisions also limits the strength of the near-term earnings outlook.
The quarter’s bookings, RPO, Oracle deployment timelines, Helios commercialization and management's confidence are important factors in achieving its 2026 revenue target of $28-$32 million. Quantinuum generated approximately $13.2 million in first-half 2026 revenues, meaning it needs $14.8-$18.8 million in second-half revenues to achieve its annual guidance.
For now, waiting for greater evidence of commercial execution appears more prudent than buying QNT solely because its shares have declined sharply.
View the Zacks #1 Rank List
Image: Bigstock
Quantinuum Q3 Preview: Should You Buy the Dip Ahead of Earnings?
Key Takeaways
Quantinuum Inc. (QNT - Free Report) is scheduled to report its third-quarter 2026 results on Nov. 5, after market close. The quantum computing company is heading into its second earnings announcement as a public company amid a steep decline in its share price and weakening investor sentiment toward pure-play quantum computing stocks.
Since the beginning of July, QNT shares have plunged 38.7%, significantly underperforming the Internet Software Market, which advanced 16.4% and the S&P 500 index, which gained 1.7%, according to the supplied Zacks price-performance data.
July-September QNT Stock Performance
Image Source: Zacks Investment Research
What Do Q3 Earnings Estimates for QNT Say?
The Zacks Consensus Estimate for Quantinuum's third-quarter 2026 revenues is pegged at $8.15 million, based on three analyst estimates. The Zacks Consensus Estimate for third-quarter bottom line is pegged at a loss of 38 cents per share, based on four analyst estimates.
The company reported second-quarter revenues of $8 million, reflecting 279% year-over-year growth. Adjusted net loss per share was 28 cents. The third-quarter consensus estimates therefore indicate modest revenue growth and a widening adjusted loss per share sequentially.
Quantinuum Inc. Price and EPS Surprise
Quantinuum Inc. price-eps-surprise | Quantinuum Inc. Quote
Strategic Progress Fails to Lift QNT Stock Amid Broader Quantum Selloff
The stock's weakness during July to September was particularly notable considering Quantinuum's strategic developments since its June 2026 initial public offering (IPO). The company announced a major partnership with Oracle (ORCL - Free Report) , strengthened its manufacturing ecosystem through a collaboration with Quanta Computer and finalized a $100 million award agreement with the U.S. Department of Commerce's CHIPS Research and Development Office. It also reported encouraging technological progress on its Helios quantum computer and continued advancing its next-generation Sol system.
However, Quantinuum is not alone in facing investor skepticism. Other pure-play quantum computing companies, including IonQ (IONQ - Free Report) and D-Wave Quantum (QBTS - Free Report) , have also struggled to sustain their share-price momentum despite significant commercial and technological developments. IonQ's revenue growth, expanded strategic partnerships and progress on its next-generation quantum systems are yet to fully offset concerns about its substantial operating losses and commercialization timelines. Similarly, D-Wave's strong bookings growth and government-backed initiatives have not insulated its shares from the broader sector correction.
The broader quantum computing sector has struggled as investors have become increasingly cautious about speculative growth stocks, commercial adoption timelines and the substantial investment required to develop fault-tolerant quantum computers. Quantinuum's relatively small revenue base and widening operating losses have added to concerns.
For the third quarter, the extent to which the company's expanding commercial ecosystem translates into stronger bookings, remaining performance obligations (RPO) and improved revenue visibility will be crucial.
Oracle Deal and Government Funding Strengthen Commercial Prospects
Quantinuum strengthened its commercial and manufacturing ecosystem through several strategic developments during July-September, which could support bookings and future revenue growth. On Aug. 11, it announced a partnership with Oracle to deploy its Helios quantum computer through Oracle Cloud Infrastructure, enabling enterprise customers to combine quantum computing with conventional high-performance computing and AI workloads. However, management indicated that much of the deal's revenue contribution would materialize upon system delivery.
On Aug. 13, Quantinuum partnered with Quanta Computer to strengthen manufacturing and systems engineering capabilities. It also finalized a $100 million award agreement with the U.S. Department of Commerce's CHIPS Research and Development Office on Sept. 8 to support domestic quantum semiconductor manufacturing and supply-chain development, alongside GlobalFoundries and Monarch Quantum.
These developments provide important indicators for the third quarter. Technology progress also remains important. Quantinuum achieved near five-nines logical fidelity on Helios and continued validating its Sol system, targeted for 2027. More than 180 organizations were developing applications on its Nexus platform in the second quarter, up from approximately 150 earlier in the year. Whether this expanding ecosystem translates into higher bookings, RPO and improved revenue visibility will be crucial to the third-quarter results.
What the Zacks Model Unveils for QNT Stock
Our proven model predicts an earnings beat for Quantinuum this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
Earnings ESP: Quantinuum has an Earnings ESP of +20.53%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Should Investors Buy QNT Stock Ahead of Q3 Earnings?
Quantinuum has several fundamental strengths, including its full-stack quantum computing platform, technological leadership in trapped-ion systems, substantial cash reserves, an Oracle partnership and government-backed manufacturing initiatives. Its expanding Nexus ecosystem and progress toward Sol also support its long-term growth prospects.
However, the company's near-term financial profile remains challenging. The Zacks Consensus Estimate indicates modest sequential revenue growth and a wider adjusted loss for the third quarter. The absence of positive earnings estimate revisions also limits the strength of the near-term earnings outlook.
The quarter’s bookings, RPO, Oracle deployment timelines, Helios commercialization and management's confidence are important factors in achieving its 2026 revenue target of $28-$32 million. Quantinuum generated approximately $13.2 million in first-half 2026 revenues, meaning it needs $14.8-$18.8 million in second-half revenues to achieve its annual guidance.
For now, waiting for greater evidence of commercial execution appears more prudent than buying QNT solely because its shares have declined sharply.